MAP4K3-DT: A Potential Drug Target and Biomarker (G728730)

Target Name: MAP4K3-DT

NCBI ID: G728730

MAP4K3-DT

Other Name(s): MAP4K3 divergent transcript

MAP4K3-DT: A Potential Drug Target and Biomarker

MAP4K3-DT, also known as MAP4K3-Divergent Transcript, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.MAP4K3-DT is a gene that encodes a protein known as Map4K3, which is a key regulator of cell proliferation and survival.

Studies have shown thatMap4K3 is highly expressed in a variety of tissues and has been implicated in the development and progression of many diseases. For example, it has been found to be highly expressed in breast tissue and has been linked to the development of breast cancer. It is also expressed in the brain and has been implicated in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.

In addition to its potential as a drug target, MAP4K3-DT has also been identified as a potential biomarker for several diseases. For example, it has been found to be highly expressed in the blood and urine of patients with Alzheimer's disease, and has been used as a biomarker for this disease in clinical trials. It is also expressed in the urine of patients with Parkinson's disease and has been used as a potential biomarker for this disease.

Another potential application of MAP4K3-DT as a drug target is its role in the regulation of cell signaling pathways. The MAP4K3 gene has been shown to be involved in a number of signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These pathways are involved in a wide range of cellular processes, including cell growth, differentiation, and survival.

Given its potential as a drug target and biomarker, MAP4K3-DT is an attractive target for researchers to study and potentially develop new treatments for a variety of diseases. Further research is needed to fully understand the role of MAP4K3-DT in disease and to develop effective treatments.

Protein Name: MAP4K3 Divergent Transcript

The "MAP4K3-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAP4K3-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets